APi Group Total Cost of Revenue decreased by 5.4% to $1.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $1.18B to $1.36B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 15.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $746.00M | $795.00M | $838.00M | $1.10B | $1.21B | $1.30B | $1.24B | $1.19B | $1.28B | $1.27B | $1.25B | $1.11B | $1.19B | $1.26B | $1.29B | $1.18B | $1.38B | $1.43B | $1.44B | $1.36B |
| QoQ Change | — | +6.6% | +5.4% | +30.7% | +10.9% | +6.7% | -4.2% | -4.1% | +7.2% | -0.2% | -1.7% | -11.4% | +6.9% | +6.2% | +2.1% | -8.5% | +16.8% | +4.2% | +0.4% | -5.4% |
| YoY Change | — | — | — | — | +62.7% | +62.9% | +48.0% | +8.6% | +5.0% | -1.7% | +0.9% | -6.7% | -7.0% | -1.1% | +2.8% | +6.1% | +15.9% | +13.8% | +11.9% | +15.7% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Safety Services | $798.00M | $856.00M | $879.00M | $887.00M | $888.00M |
| Specialty Services | $377.00M | $516.00M | $550.00M | $551.00M | $476.00M |
| Total | $1.18B | $1.38B | $1.43B | $1.44B | $1.36B |